Home About Us Product Portfolio Contact Us Business Inquiry
Our Team Research Quality Assurance Client Satisfaction Promotions
 


Ceftazidime Injection

CAS NO: 72558-82-8

Ceftazidime is a third-generation semi synthetic, broad-spectrum, beta-lactum antibiotic for parenteral administration. 
Ceftazidime is indicated for the treatment of the following infections when known or likely to be due to one or more susceptible microorganisms and when parenteral therapy is required:
- Respiratory tract infections, including lower respiratory tract infections in patients with cystic fibrosis
- Urinary tract infections; Ceftazidime may also be used for peri-operative prophylaxis during trans-urethral prostatectomy
- Skin and soft tissue infections
- Biliary tract infections
- Intra-abdominal infections
- Bone and joint infections
- Infections associated peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD)
- Meningitis due to aerobic gram-negative organisms


Photo of actual product

Product Portfolio

 

 
Home About Us Product Portfolio Contact Us Business Inquiry Our Team Research Quality Assurance Client Satisfaction Promotions